1-8 of 8
Anežka Kvetková
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Therapeutic Strategies and Outcomes in Patients with Chronic Myeloid Leukemia: A Real World Study

Sotiria Besikli-Dimou, Daniela Žáčková, Thomas Chatzikonstantinou, Eva Minga, Georgios Karakatsoulis, Christina Papaggelou, Anežka Kvetková, Maria Dimou, Panagiotis Dolgyras, Apostolia Papalexandri, Ioanna Sakellari, Panayiotis Panayiotidis, Kostas Stamatopoulos, Jiri Mayer, Anastasia Chatzidimitriou
Journal: Blood
Blood (2024) 144 (Supplement 1): 7912.
https://doi.org/10.1182/blood-2024-206935
Published: 2024
Journal Articles

Final Report: Somatic Mutations and HMGCLL1 Haplotype Are Not Associated with Molecular Relapse-Free Survival in Patients with Chronic Myeloid Leukemia Who Attempt Treatment-Free Remission

Maria Agustina Perusini, Katia Pagnano, Carolina Pavlovsky, Beatriz Moiraghi, Ana Varela, Michele Bianchini, Carmen Fava, Jiří Mayer, Daniela Žáčková, Anežka Kvetková, Tomáš Jurček, Ivana Ježíšková, Ana Beatriz Pascoal Lopes, Gislaine Borba Oliveira, Carmino De Souza, Amirthagowri Ambalavanan, Anthea Travas, Jaeyoon John Kim, Danielle Pyne, Jessie Medeiros, Sagi Abelson, Dennis Dong Hwan Kim
Journal: Blood
Blood (2023) 142 (Supplement 1): 4543.
https://doi.org/10.1182/blood-2023-189797
Published: 2023
Journal Articles

New Pattern of Emerging Somatic Mutations in Optimal Responders Following Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia Patients Evidenced from Mutational Kinetic Analysis Based on Pairwise Comparison

Gopila Gupta, May Chiu, Eshrak Al-Shaibani, Maria Agustina Perusini, Josephine Lucero, Daniela Zackova, Ivana Jeziskova, Anezka Kvetkova, Tomas Jurcek, Jaeyoon John Kim, Danielle Pyne, Anthea Travas, Amirthagowri Ambalavanan, Jiri Mayer, Jessie Medeiros, Sagi Abelson, Dennis Dong Hwan Kim
Journal: Blood
Blood (2023) 142 (Supplement 1): 4531.
https://doi.org/10.1182/blood-2023-189827
Published: 2023
Journal Articles

Real World Population- Based Data from Nationwide Registry Support the Existence of Accelerated Phase in Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients Even in Tyrosine Kinase Inhibitors (TKIs) Era

Tomas Hornak, Jiri Mayer, Petra Cicatkova, Lukas Semerad, Anezka Kvetkova, Hana Klamova, Edgar Faber, Petra Belohlavkova, Michal Karas, Lukas Stejskal, Eduard Cmunt, Olga Cerna, Dana Srbova, Hana Zizkova, Lucia Vrablova, Ivana Skoumalova, Jaroslava Voglova, Tereza Jurkova, Marika Chrapava, Tomas Jurcek, Ivana Jeziskova, Marie Jarosova, Katerina Machova Polakova, Tomas Papajik, Pavel Zak, Pavel Jindra, Daniela Zackova
Journal: Blood
Blood (2023) 142 (Supplement 1): 3166.
https://doi.org/10.1182/blood-2023-174455
Published: 2023
Journal Articles

Somatic Mutations Are Frequently Detected in CML Patients before Treatment-Free Remission (TFR) Attempt with Tyrosine Kinase Inhibitor (TKI) Discontinuation but with Uncertain Predictive Value for Tfr Failure

Maria Agustina Perusini, Katia B Pagnano, Carolina Pavlovsky, Beatriz Moiraghi, Ana Ines Varela, Michele Bianchini, Jiří Mayer, Daniela Žácková, Anežka Kvetková, Tomáš Jurček, Ivana Ježíšková, Ana Beatriz Pascoal Lopes, Gislaine B O Duarte, Carmino Antonio Souza, Jessie J.F. Medeiros, Taehyung Simon Kim, Young Seok Yoo, Kyoung Ha Kim, Hye Won Lee, Myung Hee Chang, Seong Yoon Yi, Sagi Abelson, Dennis Kim
Journal: Blood
Blood (2022) 140 (Supplement 1): 6782–6783.
https://doi.org/10.1182/blood-2022-167927
Published: 2022
Journal Articles

Somatic Mutations in Myeloid Transcription Factors and in Activated Signaling Pathway, but Not in Epigenetic Modifier Pathway, Predict the Risk of Treatment Failure and Progression to Advanced Phase in Chronic Myeloid Leukemia

Taehyung Kim, Daniela Žácková, Ivana Ježíšková, Anežka Kvetková, Tomáš Jurček, Young Seok Yoo, Hyewon Lee, Kyoung Ha Kim, Myung Hee Chang, Seong Yoon Yi, Jessie J.F. Medeiros, Sagi Abelson, Dennis Kim
Journal: Blood
Blood (2022) 140 (Supplement 1): 812–814.
https://doi.org/10.1182/blood-2022-162676
Published: 2022
Journal Articles

The Prognostic Impact of HMGCLL1 Gene Variant on Treatment Outcomes in Chronic Myeloid Leukemia (CML) Patients: Adverse Impact on the Response, Failure, and Progression with Imatinib Which Can be Abrogated By the Use of 2 nd Generation Tyrosine Kinase Inhibitor (TKI) Upfront Therapy

Maria Agustina Perusini, Taehyung Simon Kim, Daniela Žácková, Katia B Pagnano, Jiří Mayer, Carolina Pavlovsky, Ivana Ježíšková, Anežka Kvetková, Tomáš Jurček, Beatriz Moiraghi, Ana Ines Varela, Michele Bianchini, Ana Beatriz Pascoal Lopes, Gislaine B O Duarte, Young Seok Yoo, Carmino Antonio Souza, Jessie Medeiros, Hye Won Lee, Kyoung Ha Kim, Seong Yoon Yi, Myung Hee Chang, Sagi Abelson, Dennis Dong Hwan Kim
Journal: Blood
Blood (2022) 140 (Supplement 1): 6774–6775.
https://doi.org/10.1182/blood-2022-168228
Published: 2022
Journal Articles

Half: A Prospective Multi-Centre Phase II Clinical Trial Evaluating the Efficacy and Safety of Tyrosine Kinase Inhibitors' Discontinuation after Two-Step Dose Reduction in Patients with Chronic Myeloid Leukemia in Deep Molecular Remission

Daniela Žácková, Edgar Faber, Lukáš Stejskal, Michal Karas, Petra Bělohlávková, Hana Klamová, Olga Černá, Eduard Cmunt, Petra Čičátková, Lukáš Semerád, Tomáš Horňák, Anežka Kvetková, Jiřina Procházková, Jitka Rychlíčková, Radka Štěpánová, Adam Svobodník, Kateřina Machová Poláková, Ivana Ježíšková, Tomáš Jurček, Marek Borský, Ondřej Wiewiorka, Regina Demlová, Jiří Mayer
Journal: Blood
Blood (2021) 138 (Supplement 1): 3606.
https://doi.org/10.1182/blood-2021-146221
Published: 2021